BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 15800487)

  • 1. Surgical treatment of peritoneal carcinomatosis from well-differentiated digestive endocrine carcinomas.
    Elias D; Sideris L; Liberale G; Ducreux M; Malka D; Lasser P; Duvillard P; Baudin E
    Surgery; 2005 Apr; 137(4):411-6. PubMed ID: 15800487
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peritoneal carcinomatosis in patients with digestive endocrine tumors.
    Vasseur B; Cadiot G; Zins M; Fléjou JF; Belghiti J; Marmuse JP; Vilgrain V; Bernades P; Mignon M; Ruszniewski P
    Cancer; 1996 Oct; 78(8):1686-92. PubMed ID: 8859181
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of liver metastases with moderate peritoneal carcinomatosis by hepatectomy and cytoreductive surgery followed by immediate post-operative intraperitoneal chemotherapy: feasibility and preliminary results.
    Elias D; Dube P; Bonvalot S; Meshaka P; Manai M; Cavalcanti A; Lasser P
    Hepatogastroenterology; 1999; 46(25):360-3. PubMed ID: 10228822
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Two-step surgery for synchronous bilobar liver metastases from digestive endocrine tumors: a safe approach for radical resection.
    Kianmanesh R; Sauvanet A; Hentic O; Couvelard A; Lévy P; Vilgrain V; Ruszniewski P; Belghiti J
    Ann Surg; 2008 Apr; 247(4):659-65. PubMed ID: 18362629
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for the management of peritoneal carcinomatosis from colorectal cancer: a multi-institutional study.
    Glehen O; Kwiatkowski F; Sugarbaker PH; Elias D; Levine EA; De Simone M; Barone R; Yonemura Y; Cavaliere F; Quenet F; Gutman M; Tentes AA; Lorimier G; Bernard JL; Bereder JM; Porcheron J; Gomez-Portilla A; Shen P; Deraco M; Rat P
    J Clin Oncol; 2004 Aug; 22(16):3284-92. PubMed ID: 15310771
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Peritoneal carcinosis treated by complete excision and immediate postoperative intra-peritoneal chemotherapy. Phase II study in 54 patients].
    Elias D; Gachot B; Bonvallot S; Blot F; Sabourin JC; Ducreux M; Rougier P; Lasser P
    Gastroenterol Clin Biol; 1997; 21(3):181-7. PubMed ID: 9161492
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is adjuvant therapy with streptozotocin and 5-fluorouracil useful after resection of liver metastases from digestive endocrine tumors?
    Maire F; Hammel P; Kianmanesh R; Hentic O; Couvelard A; Rebours V; Zappa M; Raymond E; Sauvanet A; Louvet C; Lévy P; Belghiti J; Ruszniewski P
    Surgery; 2009 Jan; 145(1):69-75. PubMed ID: 19081477
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Critical analysis of treatment failure after complete cytoreductive surgery and perioperative intraperitoneal chemotherapy for peritoneal dissemination from appendiceal mucinous neoplasms.
    Yan TD; Bijelic L; Sugarbaker PH
    Ann Surg Oncol; 2007 Aug; 14(8):2289-99. PubMed ID: 17541772
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Advanced gastric cancer with or without peritoneal carcinomatosis treated with hyperthermic intraperitoneal chemotherapy: a single western center experience.
    Scaringi S; Kianmanesh R; Sabate JM; Facchiano E; Jouet P; Coffin B; Parmentier G; Hay JM; Flamant Y; Msika S
    Eur J Surg Oncol; 2008 Nov; 34(11):1246-52. PubMed ID: 18222622
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Treatment of the peritoneal carcinomatosis by cytoreductive surgery and intraperitoneal hyperthermic chemotherapy (IHPC): postoperative morbidity and mortality and short-term follow-up].
    Minicozzi A; Borzellino G; Momo EN; Segattini C; Pitoni F; Steccanella F; De Manzoni G
    Ann Ital Chir; 2008; 79(4):231-9. PubMed ID: 19093624
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Description of patients with midgut carcinoid tumours: clinical database from a Danish centre.
    Nykjaer KM; Grønbaek H; Nielsen DT; Christiansen P; Astrup LB
    In Vivo; 2007; 21(4):679-84. PubMed ID: 17708366
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Postoperative adverse events and long-term survival after cytoreductive surgery and intraperitoneal chemotherapy.
    Hansson J; Graf W; Påhlman L; Nygren P; Mahteme H
    Eur J Surg Oncol; 2009 Feb; 35(2):202-8. PubMed ID: 18514475
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of synchronous peritoneal carcinomatosis and liver metastases from colorectal cancer.
    Elias D; Benizri E; Pocard M; Ducreux M; Boige V; Lasser P
    Eur J Surg Oncol; 2006 Aug; 32(6):632-6. PubMed ID: 16621428
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Failure analysis of recurrent disease following complete cytoreduction and perioperative intraperitoneal chemotherapy in patients with peritoneal carcinomatosis from colorectal cancer.
    Bijelic L; Yan TD; Sugarbaker PH
    Ann Surg Oncol; 2007 Aug; 14(8):2281-8. PubMed ID: 17503156
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of two kinds of intraperitoneal chemotherapy following complete cytoreductive surgery of colorectal peritoneal carcinomatosis.
    Elias D; Benizri E; Di Pietrantonio D; Menegon P; Malka D; Raynard B
    Ann Surg Oncol; 2007 Feb; 14(2):509-14. PubMed ID: 17096054
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intraperitoneal treatment for peritoneal mucinous carcinomatosis of appendiceal origin after operative management: long-term follow-up of the Mayo Clinic experience.
    Schomas DA; Miller RC; Donohue JH; Gill S; Thurmes PJ; Haddock MG; Quevedo JF; Gunderson LL
    Ann Surg; 2009 Apr; 249(4):588-95. PubMed ID: 19300231
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The palliative benefit of aggressive surgical intervention for both hepatic and mesenteric metastases from neuroendocrine tumors.
    Chambers AJ; Pasieka JL; Dixon E; Rorstad O
    Surgery; 2008 Oct; 144(4):645-51; discussion 651-3. PubMed ID: 18847650
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatic resection of noncolorectal nonneuroendocrine metastases.
    Hemming AW; Sielaff TD; Gallinger S; Cattral MS; Taylor BR; Greig PD; Langer B
    Liver Transpl; 2000 Jan; 6(1):97-101. PubMed ID: 10648585
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of peritoneal carcinomatosis from adenocarcinoid of appendiceal origin.
    Mahteme H; Sugarbaker PH
    Br J Surg; 2004 Sep; 91(9):1168-73. PubMed ID: 15449269
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis from colorectal and gastrointestinal origin shows acceptable morbidity and high survival.
    Hagendoorn J; van Lammeren G; Boerma D; van der Beek E; Wiezer MJ; van Ramshorst B
    Eur J Surg Oncol; 2009 Aug; 35(8):833-7. PubMed ID: 19019619
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.